Evidence map›Paper›PMID 30847114›Full record

ReviewFood science & nutrition2019

Efficacy of bergamot: From anti-inflammatory and anti-oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations.

Simone Perna, Daniele Spadaccini, Leonardo Botteri, Carolina Girometta, Antonella Riva, Pietro Allegrini, Giovanna Petrangolini, Vittoria Infantino, Mariangela Rondanelli

Open access · hybridAbstract readReview
In one paragraph

Review in Food science & nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Bergamot (Foods (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. HPLC analysis andHeliyon · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Simone PernaDepartment of Biology College of Science University of Bahrain Zallaq Bahrain.ORCID 0000-0002-2720-1473
Daniele SpadacciniDepartment of Public Health, Experimental and Forensic Medicine Section of Human Nutrition, Endocrinology and Nutrition Unit Azienda di Servizi alla Persona University of Pavia Pavia Italy.
Leonardo BotteriDepartment of Public Health, Experimental and Forensic Medicine Section of Human Nutrition, Endocrinology and Nutrition Unit Azienda di Servizi alla Persona University of Pavia Pavia Italy.
Carolina GiromettaDepartment of Earth and Environmental Sciences Mycology and Plant Pathology Laboratory Pavia Italy.
Antonella RivaResearch and Development Unit Indena Milan Italy.
Pietro AllegriniResearch and Development Unit Indena Milan Italy.
Giovanna PetrangoliniResearch and Development Unit Indena Milan Italy.
Vittoria InfantinoDepartment of Public Health, Experimental and Forensic Medicine Section of Human Nutrition, Endocrinology and Nutrition Unit Azienda di Servizi alla Persona University of Pavia Pavia Italy.
Mariangela RondanelliDepartment of Public Health, Experimental and Forensic Medicine Section of Human Nutrition, Endocrinology and Nutrition Unit Azienda di Servizi alla Persona University of Pavia Pavia Italy.
University of Pavia · ITIndena (Italy) · ITUniversity of Bahrain · BH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We summarize the effects of bergamot (extract, juice, essential oil, and polyphenolic fraction) on cardiovascular, bone, inflammatory, skin diseases, mood alteration, anxiety, pain, and stress. This review included a total of 31 studies (20 studies on humans with 1709 subjects and 11 in animals (rats and mice)). In humans, bergamot-derived extract (BE) exerts positive effects on hyperlipidemia with an oral dose from 150 mg to 1000 mg/day of flavonoids administered from 30 to 180 days, demonstrating an effect on body weight and in modulating total cholesterol, triglycerides, LDL, and HDL. Studies in animals confirm promising data on glucose control (500/1000 mg/day of BE with a treatment lasting 30 days) are available in rats. In animals models, bergamot essential oil (BEO, 10 mg/kg or 20 mg/kg daily for 20 weeks) increases bone volume, decreases psoriatic plaques, increases skin collagen content, and promotes hair growth. Bergamot juice (20 mg/kg) is promising in terms of pro-inflammatory cytokine reduction. In humans, aromatherapy (from 15 to 30 min) does not appear to be useful in order to reduce stress, anxiety, and nausea, compared to placebo. Compared to baseline, BE topical application and BEO aromatherapy reduce blood diastolic and systolic pressure and could have a significant effect on improving mental conditions.

Indexed as

bergamotbonecardiovasculardiabetesinflammationskin

Identifiers

PMID30847114
PMCPMC6392855
OpenAlexW2911374797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.